/images/general/new-jersey-supreme-court-certified-attorney.png

Peter Pearlman practices primarily in the area of commercial litigation.  In addition to the federal and state courts in which he practices, he regularly represents clients before, the American Arbitration Association, the Financial Industry Regulatory Authority, and other self-regulatory organizations. He has been certified continuously by the Supreme Court of New Jersey's Board on Trial Attorney Certification as a civil trial attorney since that certification first became available in 1982. Peter has been a member of the Lawyers' Advisory Committee for the U.S. District Court District of New Jersey since 2008.

Peter has lectured on topics involving business litigation for the American Bar Association and the New Jersey Institute for Continuing Legal Education. He has taught trial advocacy for The National Institute of Trial Advocacy and trial and appellate skills at Hofstra, Widener, and Roger Williams Schools of Law. He served for ten years as trustee of the Association of the Federal Bar of New Jersey, and is a past co-chair of the Class Action Committee of the New Jersey State Bar Association.

Cases in which Peter has been involved have been the subject of more than 60 published opinions, many of which have established important legal precedents.

These days, Peter enjoys planning for and taking cruises with his wife, Joan.

  • In re: Lipitor Antitrust Litigation, 855 F.3d 126 (3d Cir. 2017) (establishing pleading standards in reverse-payments antitrust actions)
  • In re: Lipitor Antitrust Litigation, 855 F.3d 126 (3d Cir. 2017) (Clarifying the Third Circuit’s jurisdiction over reverse payment antitrust claims); also 866 F.3d 281 (3d Cir.  2017)
  • MaxLite, Inc. v. ATG Electronics, Inc., 193 F. Supp. 3d 371 (D.N.J. 2016) (Analyzing minimum contacts for specific jurisdiction in unfair competition litigation between a New Jersey plaintiff and California defendant)
  • King Drug Co. of Florence, Inc. v. SmithKline Beecham, 791 F.3d 388 (3d Cir. 2015) (the first appellate opinion to interpret the Supreme Court’s opinion in FTC v. Actavis, 133 S. Ct. 2223 (2013))
  • In re Lipitor Antitrust Litigation, 46 F. Supp. 3d 523 (D.N.J. 2014)
  • In re K-Dur Antitrust Litig., 686 F.3d 197 (3d Cir. 2012), vacated and remanded in view of Actavis v. Louisiana Wholesale Drug Co., Inc., (133 S.Ct. 2849 (2013)
  • Herman v. Yellow Pages.com, LLC, 780 F. Supp. 2d 1028 (S.D.Ca. 2011)
  • Kalow & Springut v. Commence Corp., 272 F.R.D. 397 (D.N.J. 2011)
  • State of New Jersey Department of Treasury v. Fuld, 604 F.3d 86 (3d Cir. 2010)
  • National Junior Baseball League v. Pharmanet, 720 F. Supp. 2d 517 (D.N.J. 2010)
  • In re Merck & Co. Sec., Derivative & ERISA Litig., 493 F.3d 393 (3d Cir. 2007)
  • In re AT&T Securities Litigation, 455 F.3d 160 (3d Cir. 2006)
  • In re Remeron Antitrust Litigation, 367 F. Supp. 2d 675 (D.N.J. 2005)
  • In re K-Dur Antitrust Litigation, 338 F. Supp. 2d 517 (D.N.J. 2004)
  • U.S. ex rel. Quinn v. Omnicare Inc., 382 F.3d 432 (3d Cir. 2004)
  • Varsolona v. Breen Capital Services Corp., 360 N.J. Super. 292 (App. Div. 2003), aff’d as modified, 180 N.J. 605 (2004)
  • In re Cendant Corp. Litigation, 243 F. Supp. 2d 166 (D.N.J. 2003)
  • Naviant Marketing Solutions, Inc. v. Larry Tucker, Inc., 339 F. 3d 180 (3d Cir. 2003)
  • In re Honeywell International Securities Litigation, 211 F.R.D. 255 (D.N.J. 2002)
  • In re: PSE&G Shareholder Litigation, 173 N.J. 258 (2002) (Articulating New Jersey standard for pleading shareholder derivative complaint)
  • In re: Honeywell International Securities Litigation, 182 F. Supp. 2d 414 (D.N.J. 2002)
  • In re America Online, Inc., 168 F. Supp. 2d 1359 (S.D. Fla. 2001)
  • Burgo v. Volkswagen of America, 183 F. Supp. 2d 683 (D.N.J. 2001)
  • California Public Employees Retirement System v. Chubb Corp., 127 F. Supp. 2d 572 (D.N.J. 2001)
  • Megatech, Inc. v. NSD Acquisitions LP, 215 F.3d 1320 (4th Cir. 2000)
  • In re: Nazi Era Cases Against German Defendants, 198 F.R.D. 429 (D.N.J. 2000) (billion dollar settlement achieved for the benefit of the class)
  • In re: Interneuron Pharmaceuticals Litigation, 188 F.R.D. 3 (D. Mass. 1999)
  • In re: Nice Systems Securities Litigation, 188 F.R.D. 206 (D.N.J. 1999); also 135 F. Supp 2d 551 (D.N.J. 2001)
  • Burger-Fischer v. DeGussa AG, 65 F. Supp. 2d 248 (D.N.J. 1999)
  • In re: Milestone Scientific Securities Litigation, 183 F.R.D. 404 (D.N.J. 1998), also 187 F.R.D. 165 (D.N.J. 1999), also 103 F. Supp. 2d 425 (D.N.J. 2000)
  • In re: Cendant Corporation Securities Litigation, 182 F.R.D. 144 (D.N.J. 1998)
  • In re: Computron Software Litigation, 6 F. Supp. 2d 313 (D.N.J. 1998)
  • Weikel v. Tower Semiconductor, Ltd., 183 F.R.D. 377 (D.N.J. 1998)
  • In re: Mobilemedia Securities Litigation, 28 F. Supp. 2d 901 (D.N.J. 1998)
  • In Re: PSE&G Shareholder Litigation, 315 N.J. Super. 323 (Ch. Div. 1998)
  • Matter of TDA Industries, Inc., 240 A.D. 2d 262 (N.Y.A.D. 1 Dept. 1997)
  • J.K. Funding, Inc. v. DeCara Enterprises, Ltd., 235 A.D. 2d 785 (N.Y.A.D. 3 Dept. 1997), also 270 A.D. 2d 456 (N.Y.A.D. 2 Dept. 2000)
  • Grassi v. Information Resources, Inc., 63 F. 3d 596 (7th Cir. 1995)
  • In Re: General Tire & Rubber Co. Securities Litigation, 726 F.2d 1057 (6th Cir. 1994)
  • Gelles v. TDA Industries, 44 F.3d 102 (2d Cir. 1994) (establishing new standards in the Second Circuit on the purchaser/seller requirement of SEC Rule 10b-5), also Fed. Sec. L. Rep. 1993 Transfer Binder 97,690 (S.D.N.Y. 1993), also Fed. Sec. L. Rep. 1990 Transfer Binder 96,110 (S.D.N.Y. 1991)
  • Easton & Co. v. Mutual Benefit Life Insurance Co., Fed. Sec. L. Rep. (CCH)1993 Transfer Binder 96,595, 97,294 and 97,348 (D.N.J. 1993)
  • Resolution Trust Corp. v. DiDomenico, 837 F. Supp. 623 (D.N.J. 1993)
  • Rachael Lerch, et al. v. Citizens First Bancorp, et al., 805 F. Supp. 1142 (D.N.J. 1992), also 144 F.R.D. 247 (D.N.J. 1992)
  • Franz v. Raymond Eisenhardt Sons, Inc., 732 F. Supp. 521 (D.N.J. 1990)
  • Zinberg v. Washington Bancorp, et al., 138 F.R.D. 397 (D.N.J. 1990)
  • Rose Cammer, et als. v. Bruce M. Bloom, et al., 711 F. Supp. 1264 (D.N.J. 1989)
  • Willis v. Rubiera Zim, 705 F. Supp. 205 (D.N.J. 1988)
  • Reufenacht v. O’Halleran, 737 F.2d 320 (3d Cir. 1984), aff’d, sub. nom. Gould v. Reufenacht, 471 U.S. 701 (1985) (Disavowing the sale of business doctrine defense in federal securities litigation)
  • In Re: General Public Utilities Corporation Securities Litigation, Fed. Sec. L. Rep. (CCH) 1983-1984 Transfer Binder, 99,566 (D.N.J. 1983)
  • Abramowitz v. Posner, 672 F.2d 1025 (2d Cir. 1982), also 513 F. Supp. 120 (S.D.N.Y. 1981)
  • Degenaars v. Degenaars, 186 N.J. Super. 233 (Ch. Div. 1982)
  • Turner v. Aldens, Inc., 179 N.J. Super. 596 (App. Div. 1981)
  • Roem v. Borough of Dumont, 176 N.J. Super. 397 (App. Div. 1980)
  • In re: General Tire & Rubber Co. Securities Litigation, 429 F. Supp. 1032 (J.P.M.L. 1977)
  • Scott v. Richstein, 129 N.J. Super. 516 (Law Div. 1974)
  • Crowell v. U.S., 1972 A.M.C. 2086 (D.N.J. 1972)
  • AV® rated, the highest rating conferred by Martindale-Hubbell® for legal ability and professional ethics, based upon a peer review of the Bar and the Judiciary*
  • Selected to the list of The Best Lawyers in America, Commercial Litigation*
  • Selected to the list of New Jersey Super Lawyers, 2005-present, in Business Litigation and Class Action/Mass Torts.  This award is conferred by Thomson Reuters*
  • Listed in Super Lawyers Corporate Counsel
  • Selected by the Association of the Federal Bar of the State of New Jersey and the New Jersey Commission on Professionalism in the Law as a recipient of a 2017 Professional Lawyer of the Year Award
  • Received the Lifetime Achievement Award from the New Jersey Law Journal in 2022

*No aspect of this advertisement has been approved by the Supreme Court of New Jersey. A description of the selection methodology can be found here.